- Home
- HOUR vs GNTA Comparison
HOUR vs GNTA Comparison
Compare HOUR & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOUR | GNTA |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.3M | 39.4M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HOUR | GNTA |
|---|---|---|
| Price | $2.04 | $1.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 106.3K | ★ 111.6K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $140,790,433.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $85.48 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.10 | $1.35 |
| 52 Week High | $6.90 | $10.00 |
Technical Indicators
Market Signals| Indicator | HOUR | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 48.38 | 40.49 |
| Support Level | $2.01 | $1.80 |
| Resistance Level | $2.24 | $2.20 |
| Average True Range (ATR) | 0.12 | 0.24 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 56.25 | 59.77 |
Price Performance
Historical ComparisonAbout HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.